C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C07H 21/00 (2006.01) C12N 15/11 (2006.01) C12Q 1/70 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2226438
The present invention discloses synthetic oligonucleotides complementary to contiguous and non-contiguous regions of the HCV RNA. Also disclosed are methods and kits for inhibiting the replication of HCV, inhibiting the expression of HCV nucleic acid and protein, and for treating HCV infections.
On décrit des oligonucléotides synthétiques complémentaires de régions contigües et non contigües de l'ARN du virus de l'hépatite C (VHC), de même que des procédés et des trousses permettant d'inhiber la réplication du VHC, d'inhiber l'expression de l'acide nucléique et des protéines du VHC, et de traiter les infections dues au VHC.
Frank Bruce L.
Goodchild John
Hamlin Henry A. Jr.
Kilkuskie Robert E.
Roberts Noel A.
Hybridon Inc.
Hybridon Inc.
Mbm & Co.
LandOfFree
Oligonucleotides specific for hepatitis c virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides specific for hepatitis c virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides specific for hepatitis c virus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1519833